Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy

Mitsuhiro Matsuda, Kenichi Shikata, Jun Wada, Hikaru Sugimoto, Yasushi Shikata, Toshisuke Kawasakfi, Hirofumi Makino

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Mannan binding protein (MBP) is a C-type lectin and has a high affinity to mannose and N-acetyl glucosamine. It is also known to activate C4 and C2 without C1 component, which is called 'lectin pathway'. We now report the presence of MBP and MBP-mediated complement activation in renal glomeruli of IgA nephropathy patients using an immunohistochemical method. In 7 of 42 cases with IgA nephropathy, MBP was detected in the glomerular mesangial area and colocalized with IgA1. In 19 cases with other types of IC-mediated glomerulonephritis including lupus nephritis and membranous nephropathy or without nephritis, MBP was not detected in the glomerulus. The C2- and/or C4-positive rate was 87.5% in the MBP-positive group and 20% in the MBP-negative group of IgA nephropathy. In addition, MBP-positive cases showed marked mesangial cell proliferation, lower creatinine clearance (53.4 ± 10.0 vs, 77.8 ± 4.7 ml/min) and higher urinary protein excretion (2.5 ± 0.9 vs, 0.9 ± 0.2 g/day) compared with MBP-negative cases. These findings suggested that MBP was involved in glomerular complement activation through the lectin pathway and thus induced glomerular injury of IgA nephropathy. Since oligosaccharide chain alterations such as reduced sialic acid and galactose of IgA1 molecule have been reported in IgA nephropathy patients, MBP might bind to the IgA1 molecule via interaction between MBP and sugar chain.

Original languageEnglish
Pages (from-to)408-413
Number of pages6
JournalNephron
Volume80
Issue number4
Publication statusPublished - 1998

Fingerprint

Mannose-Binding Lectin
Complement Activation
Protein Binding
Immunoglobulin A
Lectins
C-Type Lectins
Membranous Glomerulonephritis
Lupus Nephritis
Mesangial Cells
Nephritis
Glucosamine
N-Acetylneuraminic Acid
Mannose
Glomerulonephritis
Oligosaccharides
Galactose
Creatinine

Keywords

  • IgA nephropathy
  • Lectin pathway
  • Mannan binding protein

ASJC Scopus subject areas

  • Nephrology

Cite this

Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. / Matsuda, Mitsuhiro; Shikata, Kenichi; Wada, Jun; Sugimoto, Hikaru; Shikata, Yasushi; Kawasakfi, Toshisuke; Makino, Hirofumi.

In: Nephron, Vol. 80, No. 4, 1998, p. 408-413.

Research output: Contribution to journalArticle

@article{6ffa8b4212fb4da8bc97be10e10736bb,
title = "Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy",
abstract = "Mannan binding protein (MBP) is a C-type lectin and has a high affinity to mannose and N-acetyl glucosamine. It is also known to activate C4 and C2 without C1 component, which is called 'lectin pathway'. We now report the presence of MBP and MBP-mediated complement activation in renal glomeruli of IgA nephropathy patients using an immunohistochemical method. In 7 of 42 cases with IgA nephropathy, MBP was detected in the glomerular mesangial area and colocalized with IgA1. In 19 cases with other types of IC-mediated glomerulonephritis including lupus nephritis and membranous nephropathy or without nephritis, MBP was not detected in the glomerulus. The C2- and/or C4-positive rate was 87.5{\%} in the MBP-positive group and 20{\%} in the MBP-negative group of IgA nephropathy. In addition, MBP-positive cases showed marked mesangial cell proliferation, lower creatinine clearance (53.4 ± 10.0 vs, 77.8 ± 4.7 ml/min) and higher urinary protein excretion (2.5 ± 0.9 vs, 0.9 ± 0.2 g/day) compared with MBP-negative cases. These findings suggested that MBP was involved in glomerular complement activation through the lectin pathway and thus induced glomerular injury of IgA nephropathy. Since oligosaccharide chain alterations such as reduced sialic acid and galactose of IgA1 molecule have been reported in IgA nephropathy patients, MBP might bind to the IgA1 molecule via interaction between MBP and sugar chain.",
keywords = "IgA nephropathy, Lectin pathway, Mannan binding protein",
author = "Mitsuhiro Matsuda and Kenichi Shikata and Jun Wada and Hikaru Sugimoto and Yasushi Shikata and Toshisuke Kawasakfi and Hirofumi Makino",
year = "1998",
language = "English",
volume = "80",
pages = "408--413",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy

AU - Matsuda, Mitsuhiro

AU - Shikata, Kenichi

AU - Wada, Jun

AU - Sugimoto, Hikaru

AU - Shikata, Yasushi

AU - Kawasakfi, Toshisuke

AU - Makino, Hirofumi

PY - 1998

Y1 - 1998

N2 - Mannan binding protein (MBP) is a C-type lectin and has a high affinity to mannose and N-acetyl glucosamine. It is also known to activate C4 and C2 without C1 component, which is called 'lectin pathway'. We now report the presence of MBP and MBP-mediated complement activation in renal glomeruli of IgA nephropathy patients using an immunohistochemical method. In 7 of 42 cases with IgA nephropathy, MBP was detected in the glomerular mesangial area and colocalized with IgA1. In 19 cases with other types of IC-mediated glomerulonephritis including lupus nephritis and membranous nephropathy or without nephritis, MBP was not detected in the glomerulus. The C2- and/or C4-positive rate was 87.5% in the MBP-positive group and 20% in the MBP-negative group of IgA nephropathy. In addition, MBP-positive cases showed marked mesangial cell proliferation, lower creatinine clearance (53.4 ± 10.0 vs, 77.8 ± 4.7 ml/min) and higher urinary protein excretion (2.5 ± 0.9 vs, 0.9 ± 0.2 g/day) compared with MBP-negative cases. These findings suggested that MBP was involved in glomerular complement activation through the lectin pathway and thus induced glomerular injury of IgA nephropathy. Since oligosaccharide chain alterations such as reduced sialic acid and galactose of IgA1 molecule have been reported in IgA nephropathy patients, MBP might bind to the IgA1 molecule via interaction between MBP and sugar chain.

AB - Mannan binding protein (MBP) is a C-type lectin and has a high affinity to mannose and N-acetyl glucosamine. It is also known to activate C4 and C2 without C1 component, which is called 'lectin pathway'. We now report the presence of MBP and MBP-mediated complement activation in renal glomeruli of IgA nephropathy patients using an immunohistochemical method. In 7 of 42 cases with IgA nephropathy, MBP was detected in the glomerular mesangial area and colocalized with IgA1. In 19 cases with other types of IC-mediated glomerulonephritis including lupus nephritis and membranous nephropathy or without nephritis, MBP was not detected in the glomerulus. The C2- and/or C4-positive rate was 87.5% in the MBP-positive group and 20% in the MBP-negative group of IgA nephropathy. In addition, MBP-positive cases showed marked mesangial cell proliferation, lower creatinine clearance (53.4 ± 10.0 vs, 77.8 ± 4.7 ml/min) and higher urinary protein excretion (2.5 ± 0.9 vs, 0.9 ± 0.2 g/day) compared with MBP-negative cases. These findings suggested that MBP was involved in glomerular complement activation through the lectin pathway and thus induced glomerular injury of IgA nephropathy. Since oligosaccharide chain alterations such as reduced sialic acid and galactose of IgA1 molecule have been reported in IgA nephropathy patients, MBP might bind to the IgA1 molecule via interaction between MBP and sugar chain.

KW - IgA nephropathy

KW - Lectin pathway

KW - Mannan binding protein

UR - http://www.scopus.com/inward/record.url?scp=0031730769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031730769&partnerID=8YFLogxK

M3 - Article

C2 - 9832639

AN - SCOPUS:0031730769

VL - 80

SP - 408

EP - 413

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 4

ER -